Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201101045547N1
IRCT201101045547N1
Completed
Phase 2

Randomized clinical trial of the effect of oxybutinine on serteralin induced sweating in patients with depression

Medical sience university of hamedan0 sites140 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Medical sience university of hamedan
Enrollment
140
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medical sience university of hamedan

Eligibility Criteria

Inclusion Criteria

  • •Patients with major depressive disorder according to diagnostic and statistical manual IV\- TR criteria that are using serteraline as a treatment and have sweating as side effect
  • •Exclusion criteria:
  • •Patients with psychotic features; addiction; anxiety disorders; age under18 and above65 years old; patients with hypertension, cardiac disease, urinary problems, cataract, increased eye pressure; patient with personality disorder and patients who are taking the other medications

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Efficacy of oxytocin with placebo and oxytocin with propranol on the labor augmentation.Single spontaneous delivery.Spontaneous vertex delivery
IRCT138902141096N2Vice Chancellor for research-Guilan University of Medical Sciences118
Terminated
Phase 4
A double-blind randomised controlled trial of oxytocin bolus plus placebo infusion versus oxytocin bolus plus oxytocin infusion at elective caesarean section.Postpartum haemorrhageElective caesarean sectionUterine atonyReproductive Health and Childbirth - Childbirth and postnatal care
ACTRN12607000631404Monash University948
Completed
Phase 2
A course of oxytocin nasal spray (OT) to treat social problems in youth with autism spectrum disorders
ACTRN12609000513213niversity of Sydney50
Completed
Not Applicable
Study to evaluate the pharmacokinetics of oxybate formulations in healthy subjects.cataplexynarcolepsy10040998
NL-OMON43010Jazz Pharmaceuticals60
Completed
Phase 4
HERO Study - Handling Erythropoietin Resistance with Oxpentifylline
ACTRN12608000199314Australasian Kidney Trials Network53